The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Recruiting
N/A
Interventional Study
HIV Prevention
Substance Use
Mental Health Disorders
Sexually Transmitted Infections (STIs)
Chemsex
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 140 (estimated)
- Sponsor
- Institute of HIV Research and Innovation Foundation, Thailand · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Self-identified transgender women, transgender men, or non-binary persons
* Age ≥18 years
* HIV-negative
* Engaged in chemsex or substance use within past 12 months
* Able to provide informed consent
Exclusion Criteria:
• Inability to communicate in Thai sufficiently to comp…
Contacts